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ABSTRACT
The finished human genome-assemblies comprise
several hundred un-sequenced euchromatic gaps,
which may be rich in long polypurine/polypyrimidine
stretches. Human chromosome 20 (chr 20) currently
has three unfinished gaps remaining on its q-arm.
All three gaps are within gene-dense regions and/or
overlap disease-associated loci, including the
DLGAP4 locus. In this study, we sequenced 99%
of all three unfinished gaps on human chr 20,
determined their complete genomic sizes and
assessed epigenetic profiles using a combination
of Sanger sequencing, mate pair paired-end
high-throughput sequencing and chromatin, methy-
lation and expression analyses. We found histone 3
trimethylated at Lysine 27 to be distributed across
all three gaps in immortalized B-lymphocytes. In one
gap, five novel CpG islands were predominantly
hypermethylated in genomic DNA from peripheral
blood lymphocytes and human cerebellum. One of
these CpG islands was differentially methylated and
paternally hypermethylated. We found all chr 20
gaps to comprise structured non-coding RNAs
(ncRNAs) and to be conserved in primates. We
verified expression for 13 candidate ncRNAs, some
of which showed tissue specificity. Four ncRNAs ex-
pressed within the gap at DLGAP4 show elevated
expression in the human brain. Our data suggest
that unfinished human genome gaps are likely to
comprise numerous functional elements.
INTRODUCTION
Completion of the sequence analysis of the human genome
provided in-depth characterization of the physical
sequence of genomic DNA (gDNA), albeit with
numerous unﬁnished gap regions (1,2). After almost 11
years of post-analysis, these gap regions remain present
and uncharacterized in both euchromatic and heterochro-
matic regions of the human nuclear genome (3). Some of
the euchromatic gaps are ﬂanked by segmental duplica-
tions and remain technically challenging to sequence.
Alternative approaches previously used for closing some
of these gaps elsewhere in the genome, include fosmid re-
sources (4), transcript-based approaches between paired
expressed sequence tags (5), chromosome walking and
shotgun sequencing (6) and more recently sequencing by
synthesis using next-generation high-throughput 454
sequencing technology (7). None of these single
approaches has been successful in closing all the remaining
gaps in the human genome, possibly due to their unique
structural or sequence identity.
The sequence assembly of human chromosome 20 (chr
20) currently has three remaining unﬁnished gaps, all
located on the long arm (q-arm) of the chromosome (8).
All three gaps are within gene-dense euchromatic areas.
There are no segmental duplications up to a distance of
>100 kb on either side of these gaps. Since all three human
chr 20 gaps lay in gene-dense areas or overlapped loci
associated with human disorders (9,10), we hypothesized
that their molecular and transcriptional characterizations
will provide valuable insight into the regulation of sur-
rounding regions. In this study, we have successfully
sequenced 99% of the unﬁnished sequences and
determined the correct sizes of the three remaining gaps
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on human chr 20. Furthermore, we characterized their
chromatin and methylation compositions, assessed tran-
scription (predicted and actual transcripts) and measured
sequence and RNA structure conservation (Figure 1A).
MATERIALS AND METHODS
Cell culture
Epstein–Barr virus (EBV) transformation of peripheral
blood lymphocytes (PBLs) was performed using estab-
lished protocols (11). Mouse–human cell hybrid cell lines
containing only one single paternally or maternally
derived human chr 20 were generated using mouse E2
cells as published elsewhere (12). The maternally inherited
chr 20 homolog was disrupted by a chromosomal
translocation t(8:20)(p12;q11.23) that we previously
reported (13).
Sanger sequencing
Overlapping polymerase chain reaction (PCR) primers
(Supplementary Table S1) were designed using Primer 3
software (14). Touchdown PCR followed by Sanger
sequencing (15), was adopted to sequence and close chr
20 gaps using gDNA from human PBLs of multiple
controls.
Mate pair paired-end Illumina sequencing of gDNA
Mate pair paired-end sequencing of multiple gDNA
libraries was performed as previously published (16),
using an Illumina-recommended protocol and sequenced
on a Genome Analyzer II (Illumina). Genomic DNA was
Figure 1. Strategy followed to sequence and characterize previously unﬁnished human chr 20 gaps. (A) Schematic representation of experimental
workﬂow and study design. (B) BLASTN analysis of three remaining human chr 20 gaps (1, 2 and 3) in the HuRef, Celera and GRC37 (hg19)
assemblies. Stripped rectangles denote gap regions sequenced here.
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obtained from PBLs of three balanced chromosomal
translocation carriers (not used for PCR and Sanger
sequencing) with intact chr 20 homologs. Fragmented
gDNA was sonicated to sizes of 3-kb fragments.
Immunoprecipitation of hypermethylated gDNA using
his-MBD2b (MBD-Seq)
Approximately 2–4 mg of gDNA was obtained from PBLs
of either a translocation carrier (13), phenotypically
normal controls or purchased normal human cerebellum
(41-year-old male donor, Cat # TCB-4098, Capital
Biosciences) and sonicated/nebulized, followed by puriﬁ-
cation using QIAquick columns and puriﬁcation kits
(Qiagen). Immunoprecipitation (IP) was performed using
a his-tagged MBD2b (termed MBD) antibody (0.1 mg/ml)
and the MethylCollector kit (Cat # 5502, Active Motif)
according to manufacturer’s instructions followed by
high-throughput sequencing.
Methylation-sensitive restriction enzyme digestion
sequencing of gDNA
Restriction enzyme digests were performed using the
methylation-sensitive HpaII enzyme according to the
manufacturer’s instructions (New England Biolabs).
Digested gDNA was size selected using 2% agarose gel
electrophoresis. A region corresponding to 150–300 bp
was excised and puriﬁed using a gel puriﬁcation kit
(Qiagen) followed by high-throughput sequencing.
Chromatin IP sequencing
Chromatin IP (ChIP) was performed using sonicated
chromatin obtained from EBV-transformed PBLs of a
translocation carrier (13) and antibodies for histone 3
trimethylated at Lysine 27 (H3K27me3) (Active Motif,
Cat. #39155), H3+ (Abcam, Cat #ab1791) or IgG (Cell
Signaling Technology Cat #2729S) as previously pub-
lished (17) or using the ChIP-IT express kit (Cat #
53008, Active Motif) followed by high-throughput
sequencing.
High-throughput Illumina sequencing of RNA sequencing
High-throughput RNA sequencing (RNA-Seq) was per-
formed using poly-A RNA from human hippocampus
and temporal lobe (Ambion) tissues together with
paired-end sequencing adapters, an Illumina-recom-
mended sequencing protocol and run on a Genome
Analyzer II (Illumina). In addition, the Body Map 2.0
sequence data archived at the European Nucleotide
Archive (ENA) under accession ERP000546 was used
for RNA-Seq analysis of other human tissues as described
elsewhere (18).
High-throughput Illumina sequencing
Library preparation of gDNA obtained from MBD-Seq,
methylation-sensitive restriction enzyme sequencing
(MRE-Seq) and ChIP-Seq experiments was performed
using single read or paired-end adapters and sequenced
on a Genome Analyzer II according to manufacturer’s
instructions (Illumina). ENCODE raw sequenced reads
for H3K27me3 ChIP on GM12878, EBV–PBLs were
obtained from UCSC genome browser (genome.ucsc.edu)
(19). Unique sequenced reads from all high-throughput
experiments including ENCODE H3K27me3 ChIP-Seq
experiments were re-aligned to an altered hg18 assembly
that included sequence newly identiﬁed in this study for all
three chr 20 gaps (termed hg18+chr 20 gaps genome
assembly) using Bowtie (20). The 709 bp starting from
the 50-end of gap 2 was not included in the re-alignment
assembly (hg18+chr 20 gaps) ﬁle so as to not change the
genome base positions (chromosome offsets) on either side
of the gap 2 during re-alignment. Importantly, no signiﬁ-
cant reads were shown to align to this region in any
ChIP-Seq, MBD-Seq or MRE-Seq experiment. The
required numbers of unsequenced nucleotides (NNNs)
were maintained in gaps 1 and 3 as they were estimated
to be 20 and 110 kb, respectively, in the hg18 human-
genome assembly. MBD-Seq, MRE-Seq and ChIP-Seq
reads were analyzed using Cisgenome software as
published elsewhere using a false discovery rate or
<0.01 (21). ChIP-Seq data were analyzed using H3+ or
IgG as negative controls. Paired-end RNA-Seq reads had
a maximum distance of 5 kb between each pair.
In situ hybridizations
In situ hybridizations were performed using purchased
control human cerebellum brain sections (70-year-old
female donor, Cat # TCB-4089 Capital Biosciences) as
previously published (22) using Fluorescein-labeled oligos
(Supplementary Table S7). Signals were analyzed using an
MVX10 microscope, F-View black/white and Cell^P
software (Olympus).
Bisulﬁte allelic sequencing
Bisulﬁte conversion of gDNA was performed using the
Methylation Gold kit (Zymo Research) according to
manufacturer’s instructions. Bisulﬁte allelic sequencing
was performed using primers listed in Supplementary
Table S1, Methyl-speciﬁc PCR, touchdown PCR condi-
tions (15,23) and Sanger sequenced on an ABI 3730 1
DNA analyzer (Applied Biosystems). Sequence output
was analyzed using Chromas software (Technelysium)
and BLASTN (24).
Expression analysis
Complementary DNA (cDNA) was prepared from total
RNA obtained from a human multi-tissue panel
(NSGene) and human brain panel (BioCat), using
Superscript II Reverse Transcriptase (Invitrogen). Real
time PCR (RT-PCR) was performed with multiple
batches of cDNA samples, primers listed in
Supplementary Table S1 and run on the Opticon 2
thermocycler (Bio-Rad) using FastStart DNA
Masterplus SYBR green I (Roche). RT-PCR using
cDNA prepared from RNA of a human multi-region
brain panel (BioCat) was performed in duplicates or trip-
licates. Data were quantiﬁed and normalized using the
geometric mean normalization factor as published else-
where (25) and housekeeping genes: GAPDH, ATP5A1,
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COX4A, ATP6A, ALAS1, B2M, ATP8A, PBGD, G6PD
and HPRT (Supplementary Table S1).
Northern blot analysis
Northern blot analysis was performed using purchased
total human cerebellum RNA of a 26-year-old normal
human male (Cat # 4099, Capital Biosciences).
Ampliﬁed PCR products were puriﬁed using the
QIAquick puriﬁcation kit and columns (Qiagen).
Northern blotting was performed using methods pub-
lished previously (26,27) using puriﬁed PCR products
end labeled with T4 PNK and [g-32P] ATP or body
labeled by the random primer method and [a-32P] ATP
(speciﬁc activity >3000Ci/mmol, PerkinElmer).
CpG island prediction
CpG islands (Supplementary Table S3) were predicted
using previously established criteria (28,29) and the CpG
island Searcher tool (30).
Visualization of aligned high-throughput sequenced
reads in chr 20 gaps
The graphical user interface MapView (31), Cisgenome
(21) and/or the genome browser at UCSC (19) were
used to visualize short-read data for each of the gap
regions at nucleotide level, using high-throughput
MRE-Seq MBD-Seq, ChIP-Seq, RNA-Seq and mate
pair paired-end sequenced data sets.
Conservation analysis of human chr 20 gaps
The gap regions and 23 other genome assemblies were
aligned using the lastz alignment (version 1.02, gap open
penalty of O=400 and gap extension penalty of E=3)
(32). Lastz output was chained by the axtChain program
(minimum chain score of 3000 and ‘medium’ linear gap
matrix) and chained alignments were processed into nets
by chainNet and netSyntenic, which are all available from
Webb Miller’s lab at Penn State University (http://www
.bx.psu.edu/miller_lab/). Multiple alignments were created
with roast from the tba/multiz alignment program (33)
version 012909 also available from Webb Miller’s lab. A
dynamic programming range of 30 and a minimum block
size of size 1 were employed. Phylogenetic trees were ﬁrst
estimated by the neighbor joining algorithm under the
K80 distance model. The branch lengths were
maximum-likelihood estimated using the HKY85 substi-
tution model. The evolutionarily conserved elements in
the multiple alignments of the three gaps are measured
by phastCons scores (34). We let phastCons (35) itself
estimate the phylogenetic models (conserved and
non-conserved) directly from the 24-way multiple align-
ments and the previously calculated neighbor joining
trees (phastCons’ option 1).
Prediction of structured RNAs
We searched the gap regions that were not repeat masked
for known non-coding RNAs (Rfam) (36) by using
INFERNAL (E< 1E6) (37) and BLAST (E< 1E10).
We applied CMﬁnder (38) to simultaneously predict
alignment and consensus secondary structures of
syntenic sequences. The resulting RNA structural align-
ments are described by covariance models (CMs) (39)
that can be searched by INFERNAL. First, we screened
the gap regions for structured RNA motifs previously pre-
dicted by CMﬁnder (38) using INFERNAL (E< 1E6).
These motifs were found by a human genome-wide
screen similar to the screen of the ENCODE regions
(40) and ran conserved in a pool of 17 vertebrates.
Second, we run CMﬁnder on the 24-way multiple align-
ments of the gap regions (P> 60).
RESULTS
Location and Sanger sequencing of previously unﬁnished
gaps on the long arm of human chr 20
Starting from the centromere on the long arm of human chr
20, the ﬁrst unﬁnished gap is located within the DLGAP4/
SAPAP4 [discs, large (Drosophila) homolog-associated
protein 4 or PSD-95/SAP90-associated protein 4] at
position chr 20:34360500-34380499 (NCBI build 36:
hg18) (Supplementary Figure S1A). The second gap (chr
20:60524833-60551882, hg18) is distal to the C20orf200/
NCRNA00335 (Chr20 Open Reading Frame (ORF) 200/
Non-coding RNA 335) (Supplementary Figure S1B).
Whereas the third gap (chr 20:60623815-60733814, hg18)
is distal to the SLCO4A1 (Solute Carrier Organic anion
transporter family, member 4 A1) (Supplementary Figure
S1C). From here on in this study each of these unﬁnished
gaps on human chr 20 is annotated as gap 1, gap 2 and gap
3, respectively. According to the hg18 genome assembly the
three unﬁnished gaps are estimated to be 20 kb (gap 1),
27 050 bp (gap 2) and 110 kb (gap 3), respectively. The
recently released GRC37 (hg19) genome assembly did not
contain any new sequence representation for any of these
three gaps on chr 20. The sizes of these chr 20 gaps accord-
ing to theGRC37/hg19 genome assembly were estimated to
be 50 kb each and located at positions chr
20:34897086-34947085 (gap 1), chr 20:61091438-61141437
(gap 2), chr 20:61213370-61263369 (gap 3). Neither the
hg18 nor the hg19 assemblies contain the complete
gDNA sequence for any of the three remaining human
chr 20 gaps.
Here, we successfully obtained 99% nucleotide
sequence and identiﬁed the correct sizes for each of the
three remaining gaps on human chr 20. We initially
combined sequences available in the publicly released
NCBI build 36/hg18 and GRC37/hg19 or the Celera and
HuRef genome-assemblies using BLASTN (24) analysis of
their ﬂanking regions (Figure 1B). Following this, we
Sanger sequenced all three-gap regions on human chr 20
in gDNA obtained from PBLs. We identiﬁed the complete
and correct genomic sizes of all three gaps to be 9485 bp
(gap 1), 27 759 bp (gap 2) and 16 383 bp (gap 3)
(Supplementary Figure S1A–S1C), respectively. Starting
from the known sequence outside each gap we designed
overlapping PCR primers to amplify and sequence these
gaps from the outside, going inwards. BLASTN analysis
conﬁrmed that most of the sequences obtained here, have
matched with sequence already available in either the
Nucleic Acids Research, 2012, Vol. 40, No. 14 6663
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Celera or HuRef assemblies or both, albeit for some dif-
ferences in single nucleotides, possibly indicative of single
nucleotide polymorphisms (Figure 1B). None of the
sequence we obtained is represented in neither hg18 nor
hg19 genome assemblies. We also obtained novel sequence
for some regions, previously not represented in either
Celera or HuRef assemblies. Some regions that were
indeed identiﬁed as unﬁnished in the Celera and HuRef
assemblies were found to be artiﬁcial, suggesting that their
ﬂanking regions at either end were in fact joined. We
found no evidence for segmental duplications on either
side of these gaps up to a distance of <100 kb.
Mate pair paired-end Illumina sequencing of human
chr 20 gaps
Next, using paired-end sequencing of multiple mate pair
human PBL gDNA libraries we conﬁrmed sequence
identity of all three human chr 20 gaps (Figure 2A–C).
We used multiple gDNA samples, which were in
addition to the ones used for Sanger sequencing. We
modiﬁed the hg18 genome assembly in a way that the
gaps having the unsequenced nucleotides (NNN) on the
long arm of chr 20 were replaced with sequence we
obtained previously using Sanger sequencing, taking care
not to change the genome base position (chromosome
offsets) on either side of these gaps. We termed this
altered human genome assembly: hg18+chr 20 gaps. We
successfully obtained the complete sequence for gap 2 but
were unable to generate sequence for 348 bp in gap 1 and
413 bp in gap 3 due to the highly repetitive nature of
these regions as established using Sanger sequencing.
Since we obtained an individual PCR product for these
repetitive regions in gap 1 and gap 3, we were able to
estimate their sizes but unable to generate complete nu-
cleotide sequence (Supplementary Figure S1A and S1C).
Using RepeatMasker (v3.3.0) (41) and the default human
repeat database we found all the three gap regions on chr
20 to have long interspersed nuclear elements, small
interspersed nuclear elements, long transposon repeats
and simple and low complexity repeats, yet at low copy
numbers (Supplementary Table S2). Within gap 1 we
obtained novel sequence for 1052 bp within a 1400-bp
region that was not present in any genome assembly. The
sequence for the remaining 348 bp contained within this
region could not be generated due to a continuous TG
repeat.
H3K27me3 is distributed across all three human
chr 20 gaps
Following sequence analysis and identiﬁcation of the
actual sizes of the three chr 20 gaps we characterized
their chromatin distribution. H3K27me3 is associated
with repressed chromatin and is distributed on both the
ﬂanking sides of all three chr 20 gaps in most
lineage-committed and cultured immortalized human
somatic cells (42). Using ChIP-Seq we found H3K27me3
to be distributed across all three-gap regions in EBV–
PBLs (Figure 3A), suggesting them to be transcriptionally
silenced. H3K27me3 distribution across all the three gaps
was identiﬁed at the higher end of H3K27me3 distribution
for the genome.
Differentially methylated CpG island in human
chr 20 gap 2
Next, we assessed gDNA methylation (Ch3
) at the
carbon-5 residue of the cytosine base (termed 5mC) of
CpG dinucleotides across all three human chr 20 gaps.
Using MBD-Seq and MRE-Seq we found no widespread
enrichment of gDNA hypermethylation at CpG dinucleo-
tides in either gap 1 or gap 3 in PBLs or human cerebellum
(Figure 3B). However, we found hypomethylation and
hypermethylation peaks to be widespread across gap 2
in gDNA from both PBLs and human cerebellum
(Figure 3C). We identiﬁed ﬁve new CpG islands within
gap 2, including one lying at its 30-terminal end that
extended outside the gap (Figure 3C). We also used a
more stringent classiﬁcation that predominantly identiﬁes
CpG islands at the 50-end of genes (28) and identiﬁed three
CpG islands. These overlapped with the CpG islands pre-
dicted earlier in gap 2 using the less stringent criteria
(Figure 3C and Supplementary Table S3). Using
MBD-Seq we found all CpG islands in gap 2 to be pre-
dominantly enriched for hypermethylated CpGs
(Figure 3C). However, we found CpG island 4/1a within
gap 2 to have both hypomethylated and hypermethylated
peaks (Figure 3C), demonstrating it to be a differentially
methylated region (43). In order to assess whether CpG
island 4/1a was maternally or paternally methylated we
took advantage of our previously established mouse–
human E2 cell hybrid cell lines. Each cell hybrid contained
only a single paternally or maternally derived human chr
20. Bisulﬁte allelic sequencing of gDNA isolated from
these mouse–human cell hybrids showed CpG island
4/1a to be paternally hypermethylated (Figure 3D). As a
control we tested the methylation status of the paternally
expressed MCTS1 (PSIMCT-1) pseudogene and NNAT
(Neuronatin) gene located on the q-arm of human chr 20.
We conﬁrmed them to be paternally hypomethylated and
maternally hypermethylated in these mouse–human E2
cells (Supplementary Figure S2, data not shown) similar
to data reported elsewhere (44,45).
Conservation and expression analysis of human
chr 20 gaps
Since the analyzed regions are not annotated as gaps in
other organisms including primates we performed pairwise
alignments (lastz) (32) of the three gap regions including
500 bp up and downstream with several other species. We
found all three gaps on human chr 20 to be well covered
and conserved in primates but not in more distant
mammals (Figure 4A–F). Furthermore, we found evolu-
tionary conserved elements to be present in each human
chr 20-gap region (Supplementary Figure S3A–S3C). The
multiple alignments of the gap regions are slightly more
conserved than the 17-way UCSC multiple alignments
that cover around 50% of the human (hg18) genome.
This is mostly due to the primate speciﬁcity of gap
regions and presence of many regions of low complexity
within these gaps. In order to assess transcriptional
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activity within the chr 20 gaps, we initially screened for
ORFs using the ORF ﬁnder at NCBI (46) and a minimum
gDNA region of >300 bp. We predicted 6 ORFs in gap 1;
38 ORFs in gap 2 and 24 ORFs in gap 3 (Supplementary
Table S4). Most ORFs in gap 2 overlapped with
hypermethylation peaks identiﬁed (Figure 3C and
Supplementary Tables S4).
Using an in house non-coding RNA (ncRNA) annota-
tion pipeline (47) we searched for known as well as de novo
predicted RNA structures. Structural homology to known
ncRNAs from Rfam v10.0 (48) was searched using tools in
the INFERNAL package. Structural similarity to known
ncRNAs from Rfam v10.0 was searched using tools in the
INFERNAL package and BLAST. INFERNAL tools
were also used to search for structural similarity to
CMﬁnder-generated models of de novo ncRNA structure
predictions elsewhere in the genome. These CMﬁnder
models comprise structural features conserved in several
vertebrate genomes. In addition, the generated 24-way
multiple alignments of the gap regions were screened by
CMﬁnder to ﬁnd models of novel structured RNA motifs.
Expression from these gaps was subsequently assessed
using the multi-tissue RNA-Seq Body map 2.0 data.
Though there are no matches to known ncRNAs in
these gap regions, we predicted 16 structured RNA
motifs in the multiple alignments of the gap regions
(Supplementary Tables S5) and 19 additional structured
RNAs in fourteen regions similar to RNA structures else-
where in the genome (Supplementary Tables S6) with
variable sizes of <250 nt. The amount of RNA structures
is slightly lower in the gap regions compared to the
conserved RNA structures in the human genome (pre-
dicted by CMﬁnder with pscore 60; data not shown).
Sixteen of the structured RNAs are <50 nt (12 from the
ﬁrst and 4 from the second set of predictions) and 4 others
originate from the same genomic locus. We chose to
validate expression for the remaining 11 candidates with
similar conserved structure elsewhere in the human
genome (Supplementary Tables S7 and S8). These
ncRNAs are mostly primate speciﬁc in the gap regions
and thus predicted with low scores from the 24-way
multiple alignments (due to short evolutionary
distances).Three of these ncRNA candidates (numbers 5,
6 and 9) are present in gap 1 and a set of four ncRNA
Figure 2. Mate pair paired–end Illumina sequencing of human chr 20 gap regions. (A-C) Representative UCSC genome browser views of mate pair
paired–end Illumina sequenced unique reads aligned to the three human chr 20 gap regions using the edited hg18+chr 20 gaps human genome
assembly. Overlapping mate pair paired-end reads align across all three chr 20 gap. Regions are drawn to scale without disturbing chromosome
offsets.
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Figure 3. Chromatin distribution and DNA methylation proﬁle across human chr 20-gap regions. (A) H3K27me3 is distributed across all three
human chr-20 gap regions in EBV-PBLs. (B) MRE-Seq (hypomethylated) and MBD-Seq (hypermethylated) aligned peak reads within gaps 1 and 3.
Methylation distribution is similar in PBL and human cerebellum for both gaps 1 and 3. (C) Methylation proﬁle of gap 2 shows it to be enriched for
both hypomethylated and hypermethylated CpGs, respectively. CpG island 4/1a (red rectangle) is enriched for both MBD-Seq and MRE-Seq reads
suggesting it to be a differentially methylated locus. CpG islands 2–6 were annotated using the classiﬁcation: 500-bp region of genomic DNA with
50% CG content and an observed CpG to expected CpG ratio of 0.6. CpG islands 1a–3a were classiﬁed based on a CpG island being a 500-bp
region of genomic DNA with 55% CG content and an observed CpG to expected CpG ratio of 0.65. Images are drawn to scale. (D) Differentially
methylated and paternally hypermethylated CpGs island 4/1a within gap 2 using bisulﬁte allelic sequencing and gDNA from mouse–human cell
hybrid cell lines or diploid human cells.
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candidates each are in gap 2 (numbers 1, 4, 7 and 8) and
gap 3 (numbers 2, 3, 10 and 11).
Candidate ncRNA numbers 10 and 11 originated from
the same genomic region in gap 3. Using BLASTN
(E: <1e157) we found no signiﬁcant overlap in sequence
between the ncRNA candidates and coding sequences
anywhere else in the human genome (hg18 genome
assembly and data not shown). We initially validated ex-
pression of all 11 CMﬁnder-predicted structured ncRNAs
using universal human reference total RNA. Using qPCR
and gel electrophoresis we identiﬁed the sizes of all
products ampliﬁed to be of the predicted size
(Figure 5A). To assess tissue speciﬁcity of four randomly
chosen candidate ncRNAs we selected two candidate
ncRNAs each from gap 1 (numbers 5 and 9) and gap 2
(numbers 7 and 8) and assessed their tissue-wide expres-
sion using total RNA from a multi-tissue human panel.
Both ncRNA candidate numbers 5 and 9 are expressed in
a tissue-speciﬁc manner and predominantly in human
brain regions (Figure 5B). Candidate numbers 7 and 8
are similarly expressed in a tissue-speciﬁc manner in
tissues including the colon and kidney but at low levels
in the brain (Figure 5B). Since ncRNA candidate numbers
5, 6 and 9 are expressed from the DLGAP4 locus known
to be highly expressed in the rat brain (49), we quantiﬁed
their expression in the human brain. We found all three
candidate ncRNAs to be widely expressed in the human
brain with elevated expression in the cerebellum, occipital
and temporal lobes (Figure 5C). Their covariant CMﬁnder
predicted ncRNA structures are conserved in the same
organisms including macaque, mouse, rat, cow and dog
(Figure 5D). The predicted structures and conservation of
all putative ncRNAs are listed in Supplementary Tables
S4 and S5 excluding candidate ncRNA number 8 as it had
a weakly conserved predicted secondary structure despite
of its statistical signiﬁcance calculated by INFERNAL.
We determined that the DLGAP4 mRNA isoform is
expressed speciﬁcally in human brain samples
Figure 4. Conservation analysis of human chr 20 gaps. The coverage versus pairwise sequence identity of 23 organisms are shown as scatterplots for
gap 1 (A), gap 2 (B) and gap 3 (C). Primates are clearly separated from more distant organisms. In the phylogenetic trees, gap 1 (D), gap 2 (E) and
gap 3 (F) are all seen to be clustered together with primate species. Phylogenetic trees (generated from the 24-way multiple alignments) show all three
human gaps regions tightly clustered with primates.
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(Supplementary Figure S4A). Using qPCR we found no
inclusion of sequences from gap 1 transcribed into the
mRNA sequence of DLGAP4 isoform a (data not
shown). Subsequently, we characterized the spatial and
temporal expressions of ncRNA candidate number 5 in
gap 1, expressed from within this brain-speciﬁc DLGAP4
locus in the human brain. This candidate ncRNA number
5 expressed from the sense strand was highly expressed in
Figure 5. De novo prediction and experimental veriﬁcation of structured ncRNAs within human chr 20 gaps. (A) Expression conﬁrmation of
ncRNAs predicted by CMﬁnder using total universal reference RNA. (B) Expression of candidate ncRNAs in a human multi-tissue RNA panel.
(C) Elevated expression of candidate ncRNAs: 5, 6, 9 and 12 in a human multi-region brain panel. (D) RNA structure of ncRNA numbers: 5, 6, 9
predicted using INFERNAL. The Vienna RNA conservation coloring scheme highlights the mutational pattern with respect to the structure and a
circle around a variable base(s) marks consistent and compensatory mutations. The color coding is explained in a color scheme legend. There are six
different canonical base pairs (G-C, C-G, A-U, U-A, G-U, U-G) described by the different colors (x-axis), and if the base pair is not supported in a
sequence of the alignment the color shading gets lighter (y-axis, incompatible pairs). (E) Candidate ncRNA number 5 is speciﬁcally expressed in the
nucleus of Purkinje cells in the human cerebellum. (F) Localized view of the DLGAP4 promoter (chr 20:34,355,500–34,385,499, hg18+chr 20 gaps)
showing candidate ncRNAs in gap 1. RNA-Seq tracks show forward and reverse aligned reads in blue and green, respectively.
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Purkinje neurons in the cerebellum similar to the
DLGAP4 mRNA isoform a (Figure 5E, data not
shown). Importantly, we found candidate ncRNA
number 5 to be expressed in a speciﬁcally localized
manner in the nucleus of Purkinje neurons (Figure 5E)
attributing it a possible regulatory role. We ruled out
the possibility of these candidate ncRNAs as being add-
itional non-coding exons of DLGAP4 mRNA isoform as
no sequence from the gap was transcribed to mature
DLGAP4 mRNA isoform a transcript (data not shown).
We next asked if any other transcribed elements could
be identiﬁed through an independent high-throughput
RNA-Seq approach. We found some overlap of predicted
structured ncRNAs within gap 1 in RNA samples from
different regions of the human brain (Figure 5F,
Supplementary Figure S4A and Supplementary Tables
S5 and S6). However, most regions predicted using
CMﬁnder as candidate ncRNAs were not identiﬁed in
the RNA-Seq data sets. Furthermore, we found one add-
itional transcript (ncRNA candidate number 12,
Figure 5F and Supplementary Table S6) expressed from
the sense strand in gap 1 and in different regions of the
brain. We also found one additional transcript in gap 2
speciﬁcally expressed in RNA from PBLs (termed candi-
date ncRNA number 13, Supplementary Figure S4B and
Supplementary Table S6) using the RNA-Seq BodyMap
2.0 data set. Candidate ncRNA numbers 12 and 13 were
identiﬁed using RNA-Seq and not by CMﬁnder/
INFERNAL predictions. Quantiﬁcation of ncRNA
number 12 in our multi-region human brain panel
identiﬁed it to be elevated in expression in brain regions
that was similar to the expression pattern of the other
ncRNA candidate’s numbers 5, 6 and 9 identiﬁed previ-
ously (Figure 5C). RNA-Seq data also identiﬁed ncRNA
candidate number 13 expressed in PBLs to have two po-
tential exons with total size of 680 bp (Supplementary
Figure S4C). None of the candidate ncRNAs identiﬁed
here was present in any repetitive elements
(Supplementary Table S2).
DISCUSSION
In this study, we have successfully sequenced three previ-
ously unﬁnished gaps on the q-arm of human chr 20. With
the addition of these 52 866 sequenced nucleotides, the full
size and sequence of chr 20 is now complete with the ex-
ception of short repeat stretches in gap 1 (348 bp) and
gap 3 (413 bp). We determined the complete sizes of all
three remaining gaps on human chr 20 as 9485 bp (gap 1),
27 759 bp (gap 2) and 16 383 bp (gap 3) using gDNA from
multiple normal individuals using Sanger sequencing and
high-throughput mate pair sequencing. This conﬁrms the
robustness of the methodologies used here for sequencing
of previously unﬁnished human genome gaps. Analysis at
the outset in BLASTN of these human chr 20 gaps while
including the data from the Celera and HuRef assemblies
revealed that sequence present in one assembly (Celera or
HuRef) was sometimes identiﬁed as a gap in the other
assembly or vice versa. Most of the remaining unﬁnished
regions in the Celera and HuRef assemblies were
complemented each other and were similarly sized to
what we obtained in this study but were not present at
all in the hg18 or hg19 genome assemblies. Although the
hg19/GRC37 genome assembly was released to include
further sequencing coverage of the human genome, no
sequence representation for these chr 20 gaps was made
(50). A similar approach may be applied to re-sequence
and close other remaining unﬁnished gaps of the human
genome. However, for this approach to be successful there
should be no segmental duplications ﬂanking the immedi-
ate gap region on either side. In addition, some sequence
should be represented in either the publicly released Celera
or HuRef genome assemblies. Although sequencing of
these gaps is not trivial, a systematic approach based on
a combination of techniques used here and in other studies
(4,7) applied together, may help in closing the remaining
unﬁnished human genome euchromatin gaps.
Evidence from previous studies has shown gap regions
to be rich in purine and/or pyrimidine stretches that are
known to form Z-DNA structures (51). However, we
found long stretches of TG and CT repeats in two of
the three remaining human chr 20-gap regions. The repeti-
tive nature of these sequences render them problematic to
cloning techniques including those used in the human
genome project (1). Gap 1 is comprised of >500 bp of
GT and >300 bp of CT continuous nucleotide repeats.
Gap 2 contains long repeats, however, gap 3 contains a
>400 bp CCATC stretch. Some of these sequences are
present in the publicly released Celera genome assembly,
suggesting the shotgun approach may have assisted in
their sequencing and assembly (52). The latter is supported
by our ability to align human mate pair paired-end
genomic reads from multiple and independent experiments
to these gap sequences. We did try to sequence the remain-
ing >500 bp regions in gaps 1 and 3 using unmapped
mates from our Illumina sequence assemblies and one
other independent source (SRA accession ERX009608),
however, we were unable to obtain enough coverage to
close them.
We characterized ﬁve novel CpG islands within gap 2
in gDNA from PBLs and human cerebellum tissue, three
of which are GC rich. We also identiﬁed CpG island
4/1a to be differentially methylated and paternally
hypermethylated. Human chr 20 has several maternally
imprinted genes most of which are paternally expressed
(44,45). Since we found CpG island 4/1a in gap 2 to be
paternally methylated, we speculate that expression at this
locus may occur from its maternally inherited
hypomethylated allele in a tissue-speciﬁc manner.
Evidence from recent studies has shown tissue-speciﬁc ex-
pression of certain loci in the nuclear genome may be
regulated by cis/trans acting ncRNAs. Emerging func-
tional roles for ncRNAs in regulating the expression of
loci highly expressed in the brain and involved in
regulating pluripotency and neurogenesis is also
becoming increasingly evident (53,54). Taking these obser-
vations into consideration, we searched human chr 20
gaps for ncRNAs using a combination of computational
analyses and high-throughput RNA-Seq. We conﬁrmed
expression of a total of 13 (11 CMﬁnder/INFERNAL
predicted structured ncRNAs and 2 identiﬁed using
Nucleic Acids Research, 2012, Vol. 40, No. 14 6669
Downloaded from https://academic.oup.com/nar/article-abstract/40/14/6660/2414617
by guest
on 17 April 2018
RNA-Seq) candidate ncRNAs in these 3 human chr 20
gaps. CMﬁnder and INFERNAL have been used to
predict conserved RNA secondary motif structures else-
where in the human genome (38,40). We found most of
these predicted ncRNAs to have structural similarity to
other RNA structures transcribed elsewhere in the
human genome, most of which were also found in other
vertebrates.
Almost any genomic locus can theoretically fold into
thermodynamically predicted RNA secondary structures,
which is what RNAfold calculates. It has also been shown
that secondary structure alone is statistically insigniﬁcant
for the detection of putative ncRNAs (55). On the other
hand, agreement in the literature exists for comparative
sequence analysis and comparison to structural back-
ground as a means to discover real and/or functional
ncRNAs (38,56,57). Therefore, the applied prediction
method using CMﬁnder accounts for thermodynamics
and compensatory base pair changes (A-U in human
and G–C in mouse) in structurally re-aligned sequences
from 18 different vertebrate genomes and compares the
signal to the structural background for ﬁnding statistically
signiﬁcant ncRNA structures.
Quantiﬁcation of ncRNA numbers 5, 6, 9 and 12 in the
human brain panel identiﬁed all four to be elevated in the
human cerebellum. Furthermore, we found ncRNA
number 5 to be expressed in speciﬁc regions of Purkinje
neuron cells in adult human cerebellum. These candidate
ncRNAs are expressed at elevated levels in the brain and
from within the DLGAP4 locus coding for the
brain-speciﬁc DLGAP4 mRNA isoform a. Their elevated
expression in the human brain and high clustering in
certain regions of the Purkinje cells including the nucleus
may in fact drive expression of DLGAP4 mRNAs or other
mRNAs in the brain. We speculate that putative ncRNAs
characterized here may have roles in the regulation of
disease-linked loci at 20q (9,10). Since we found candidate
ncRNA numbers 12 and 13 using high-throughput
RNA-Seq and not by prediction-based methods, we
suggest a combination of approaches should be used to
identify new putative ncRNAs in other regions of the
human genome as well. Northern blot analysis using
total RNA from whole-human brain and human cerebel-
lum tissues together with randomly or end-labeled PCR
ampliﬁed probes corresponding to three putative
structured ncRNA numbers 5, 6 and 9 failed to reveal
their size (data not shown). This may be due to the
small length of each probe (<250 bp) used and the fact
that this was based solely on the size of the predicted
structural part. Furthermore, these ncRNAs are expressed
at relatively low levels compared to mRNAs as evidenced
by qPCR and may exist as multiple transcripts of varying
length or spliced variants making them more difﬁcult to
detect by northern blot analysis. Difﬁculties associated
with the conﬁrmation of ncRNAs by northern blot
analysis have previously been reported (58,59).
Analyzing ﬂanking regions on either side of these three
human chr 20 gaps identiﬁed them as being conserved in
primates and having evolutionary conserved elements
within them. From an evolutionary perspective this area
of chr 20 is dense in genes associated with development
and its rather low conservation suggests functions unique
to primates and especially Homo sapiens. Further work
would be necessary to understand the speciﬁc nature and
functional signiﬁcance of these expressed transcripts, if
any. In conclusion, our study shows that unﬁnished eu-
chromatic gaps in the human genome may harbor speciﬁc
epigenetic domains and contain conserved genomic
elements with regulatory potential, including differentially
methylated CpG-islands and other functional elements, as
well as ncRNA genes, the function of which is now open
for further study.
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